CA2805980A1 - Combination of siloxane and active ingredient for treating dental disorder - Google Patents

Combination of siloxane and active ingredient for treating dental disorder Download PDF

Info

Publication number
CA2805980A1
CA2805980A1 CA2805980A CA2805980A CA2805980A1 CA 2805980 A1 CA2805980 A1 CA 2805980A1 CA 2805980 A CA2805980 A CA 2805980A CA 2805980 A CA2805980 A CA 2805980A CA 2805980 A1 CA2805980 A1 CA 2805980A1
Authority
CA
Canada
Prior art keywords
active ingredient
pharmacologically active
pharmaceutical composition
siloxane
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2805980A
Other languages
English (en)
French (fr)
Inventor
Hans H. Schulz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Innovation GmbH
Original Assignee
Bayer Innovation GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Innovation GmbH filed Critical Bayer Innovation GmbH
Publication of CA2805980A1 publication Critical patent/CA2805980A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/50—Preparations specially adapted for dental root treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/69—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
CA2805980A 2010-07-21 2011-07-13 Combination of siloxane and active ingredient for treating dental disorder Abandoned CA2805980A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10007536.5 2010-07-21
EP10007536A EP2409702A1 (en) 2010-07-21 2010-07-21 Combination of siloxane and active ingredient for treating dental disorder of hard tissues
PCT/EP2011/061953 WO2012010478A1 (en) 2010-07-21 2011-07-13 Combination of siloxane and active ingredient for treating dental disorder

Publications (1)

Publication Number Publication Date
CA2805980A1 true CA2805980A1 (en) 2012-01-26

Family

ID=43038027

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2805980A Abandoned CA2805980A1 (en) 2010-07-21 2011-07-13 Combination of siloxane and active ingredient for treating dental disorder

Country Status (11)

Country Link
US (1) US20130184239A1 (cg-RX-API-DMAC7.html)
EP (2) EP2409702A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013531048A (cg-RX-API-DMAC7.html)
KR (1) KR20130043203A (cg-RX-API-DMAC7.html)
CN (1) CN103096890A (cg-RX-API-DMAC7.html)
AU (1) AU2011281719A1 (cg-RX-API-DMAC7.html)
BR (1) BR112013001492A2 (cg-RX-API-DMAC7.html)
CA (1) CA2805980A1 (cg-RX-API-DMAC7.html)
MX (1) MX2013000800A (cg-RX-API-DMAC7.html)
RU (1) RU2013107451A (cg-RX-API-DMAC7.html)
WO (1) WO2012010478A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2699371C1 (ru) * 2018-12-06 2019-09-05 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) Стоматологическая паста для временного пломбирования каналов корней зубов при лечении хронического деструктивного периодонтита

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11180841A (ja) * 1997-12-15 1999-07-06 Lion Corp 口腔用組成物
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
JP2001354535A (ja) * 2000-06-13 2001-12-25 Lion Corp 口腔用組成物
JP2002179569A (ja) 2000-12-12 2002-06-26 Lion Corp 口腔用組成物
EP1472263B1 (de) 2001-11-13 2006-08-30 GE Bayer Silicones GmbH & Co. KG Verwendung von siloxanen als verdampfbare träger
EP1443892B1 (en) 2001-11-15 2009-06-10 Laboratorios Miret, S.A. Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care
JP2004107310A (ja) * 2002-09-13 2004-04-08 Lion Corp 口腔用組成物
WO2007013175A1 (ja) 2005-07-29 2007-02-01 Takeshi Tanaka 歯用漂白剤
GB0518769D0 (en) 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations

Also Published As

Publication number Publication date
RU2013107451A (ru) 2014-08-27
AU2011281719A1 (en) 2013-02-21
EP2595626A1 (en) 2013-05-29
JP2013531048A (ja) 2013-08-01
US20130184239A1 (en) 2013-07-18
BR112013001492A2 (pt) 2016-05-31
KR20130043203A (ko) 2013-04-29
CN103096890A (zh) 2013-05-08
WO2012010478A1 (en) 2012-01-26
EP2409702A1 (en) 2012-01-25
MX2013000800A (es) 2013-02-27

Similar Documents

Publication Publication Date Title
AU784496B2 (en) Use of chemotherapeutic agents
JP2022164947A (ja) 高張性抗微生物治療用組成物
Rajsheker et al. Obturating materials used for pulpectomy in primary teeth-a mini review
JP2004501063A5 (cg-RX-API-DMAC7.html)
JPH03128316A (ja) 液体重合体組成物及びその使用方法
Louwakul et al. The effect of 2% chlorhexidine as root canal irrigant in pulpectomies of primary molars
CA2805980A1 (en) Combination of siloxane and active ingredient for treating dental disorder
Madison et al. Medications and temporaries in endodontic treatment
Mendoza et al. Evolution and prognosis of necrotic primary teeth after pulpectomy
Manuel et al. Non-surgical endodontic therapy using triple-antibiotic paste
JP5390767B2 (ja) 細菌性口腔内疾患の治療用組成物、洗浄用処理液、止血用処理液、及び、細菌性口腔内疾患の治療方法
Manhas et al. Obturating materials in pediatric dentistry: Literature review
Ersahan et al. Irritant contact dermatitis due to accidental contact of formocresol used in endodontic treatment: a case report
Hussein et al. Treatment of Infected Primary Teeth using Modified Antibiotic Paste
Triveni et al. Clinical Use of Lesion Sterilization and Tissue Repair (LSTR) in Primary and Permanent Teeth: A Comprehensive Review
AU2005202737B2 (en) Use of chemotherapeutic agents
Siddique et al. Effect of Ledermix Paste versus Calcium Hydroxide on Inter-Appointment Pain during Root Canal Therapy
WO2009107098A2 (en) An oral treatment composition

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20160713